Cost-effectiveness of treatment sequences for BRAF-mutant advanced melanoma in the Netherlands using a health economic model is a research paper published in European Journal of Cancer (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
ZonMw
Grant: 836002002
Erasmus Medisch Centrum
FWCI
0.66
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords